Company

GelMEDIX

Biotechnology Research Cambridge, Ma, United States 12 employees

Employees: 12
Contacts: 3
Emails: 3
Phones: 2

www.gelmedix.com LinkedIn Crunchbase

GelMEDIX Overview

Headquarters: Cambridge, Ma, United States
Website: www.gelmedix.com
Industry: Biotechnology Research
Employees: 12
Founded: 2020
Funding: 1.9M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About GelMEDIX

GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision. GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA). Our proprietary photo-crosslinked hydrogels uniquely enable bioadhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies. Our lead program is an integrated hydrogel cell therapy designed to restore vision for macular degeneration patients with Dry AMD and GA.

GelMEDIX Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

GelMEDIX Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nasim Annabi	Associate Professor at Ucla	Los Angeles, California, United States	Email Phone
Max Cotler	COO @ Gelmedix - Engineering Ocular Cell Therapy - Phd, Medical Engineering	Cambridge, Massachusetts, United States	Email
Michael Cima	Professor at Mit		View
Purnanand Sarma	Chief Executive Officer, Aro Biotherapeutics. Serial Biotech Executive/entrepreneur/investor. President-tie Boston, Ex President &ceo and Board	Carlisle, Massachusetts, United States	Email Phone